Viewing Study NCT07195227


Ignite Creation Date: 2025-12-25 @ 5:08 AM
Ignite Modification Date: 2026-01-26 @ 4:54 AM
Study NCT ID: NCT07195227
Status: NOT_YET_RECRUITING
Last Update Posted: 2025-10-02
First Post: 2025-06-10
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Efficacy and Safety of Camizestrant Plus Ribociclib in Patients With Breast Cancer
Sponsor: MedSIR
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Hormon Receptor Positive Breast Cancer View
None Breast Cancer View
Keywords: